Europace
Công bố khoa học tiêu biểu
Sắp xếp:
Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells
Europace - Tập 9 Số 3 - Trang 167-171 - 2007
Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMergeTM Italian Registry
Europace - Tập 11 Số 8 - Trang 1004-1010 - 2009
Typical atrial flutter ablation outcome: correlation with isthmus anatomy using intracardiac echo 3D reconstruction
Europace - Tập 6 Số 5 - Trang 407-417 - 2004
Impact of variant pulmonary vein anatomy and image integration on long-term outcome after catheter ablation for atrial fibrillation
Europace - Tập 12 Số 12 - Trang 1691-1697 - 2010
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study Abstract
Aims
To assess the clinical relevance of a history of atrial fibrillation (AF) in hospitalized patients with coronavirus disease 2019 (COVID-19).
Methods and results
We enrolled 696 consecutive patients (mean age 67.4 ± 13.2 years, 69.7% males) admitted for COVID-19 in 13 Italian cardiology centres between 1 March and 9 April 2020. One hundred and six patients (15%) had a history of AF and the median hospitalization length was 14 days (interquartile range 9–24). Patients with a history of AF were older and with a higher burden of cardiovascular risk factors. Compared to patients without AF, they showed a higher rate of in-hospital death (38.7% vs. 20.8%; P < 0.001). History of AF was associated with an increased risk of death after adjustment for clinical confounders related to COVID-19 severity and cardiovascular comorbidities, including history of heart failure (HF) and increased plasma troponin [adjusted hazard ratio (HR): 1.73; 95% confidence interval (CI) 1.06–2.84; P = 0.029]. Patients with a history of AF also had more in-hospital clinical events including new-onset AF (36.8% vs. 7.9%; P < 0.001), acute HF (25.3% vs. 6.3%; P < 0.001), and multiorgan failure (13.9% vs. 5.8%; P = 0.010). The association between AF and worse outcome was not modified by previous or concomitant use of anticoagulants or steroid therapy (P for interaction >0.05 for both) and was not related to stroke or bleeding events.
Conclusion
Among hospitalized patients with COVID-19, a history of AF contributes to worse clinical course with a higher mortality and in-hospital events including new-onset AF, acute HF, and multiorgan failure. The mortality risk remains significant after adjustment for variables associated with COVID-19 severity and comorbidities.
Europace - Tập 23 Số 10 - Trang 1603-1611 - 2021
Atrial fibrillation burden during the coronavirus disease 2019 pandemic Abstract
Aims
The aim of this study is to determine the association between the coronavirus disease 2019 (COVID-19) pandemic and atrial fibrillation (AF) occurrence in individuals with cardiac implantable electronic devices (CIEDs).
Method and results
Multi-centre, observational, cohort study over a 100-day period during the COVID-19 pandemic (COVID-19) in the USA. Remote monitoring was used to assess AF episodes in patients with a CIED (pacemaker or defibrillator; 20 centres, 13 states). For comparison, the identical 100-day period in 2019 was used (Control). The primary outcomes were the AF burden during the COVID-19 pandemic, and the association of the pandemic with AF occurrence, as compared with 1 year prior. The secondary outcome was the association of AF occurrence with per-state COVID-19 prevalence. During COVID-19, 10 346 CIEDs with an atrial lead were monitored. There were 16 570 AF episodes of ≥6 min transmitted (16 events per 1000 patient days) with a significant increase in proportion of patients with AF episodes in high COVID-19 prevalence states compared with low prevalence states [odds ratio 1.34, 95% confidence interval (CI) 1.21–1.48, P < 0.001]. There were significantly more AF episodes during COVID-19 compared with Control [incident rate ratio (IRR) 1.33, 95% CI 1.25–1.40, P < 0.001]. This relationship persisted for AF episodes ≥1 h (IRR 1.65, 95% CI 1.53–1.79, P < 0.001) and ≥6 h (IRR 1.54, 95% CI 1.38–1.73, P < 0.001).
Conclusion
During the first 100 days of COVID-19, a 33% increase in AF episodes occurred with a 34% increase in the proportion of patients with AF episodes observed in states with higher COVID-19 prevalence. These findings suggest a possible association between pandemic-associated social disruptions and AF in patients with CIEDs.
Clinical TRIAL registration
Australian New Zealand Clinical Trial Registry: ACTRN12620000692932.
Europace - Tập 23 Số 9 - Trang 1493-1501 - 2021
The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Rhythm Association survey
Europace - Tập 18 Số 4 - Trang 623-627 - 2016
Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases
Europace - Tập 12 Số 3 - Trang 371-377 - 2010
Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility
Europace - Tập 19 Số 8 - Trang 1272-1279 - 2017
Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and meta-analysis
Europace - - Trang euw113
Tổng số: 41
- 1
- 2
- 3
- 4
- 5